Dr. Margie Morgan shares how Cedars-Sinai plans to slash respiratory testing costs with the LIAISON PLEX^® RSP Flex Assay.

Traditional syndromic panels often over-test and overcharge. Cedars-Sinai adopted a new approach with Flexible Syndromic Testing—custom panels, scaled pricing based on what is reported, and the ability to instantly report additional findings without rerunning the assay.

Learn how this approach:

• Can save up to 50% on reagent costs*
• Supports stewardship and operational efficiency
• Aligns with reimbursement guidelines
• Streamlines testing across departments on a single platform